J & M Shuler Medical Inc is categorized under Commercial Biotechnical Research in Athens, GA and active since 2011.
J & M Shuler Medical Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Michael Shuler at the company’s single location by writing to 530 West Cloverhurst Avenue, Athens, Georgia GA 30606 or by phoning (706) 424-8438. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | J & M Shuler Medical Inc |
| Contact Person: | Michael Shuler |
| Address: | 530 West Cloverhurst Avenue, Athens, Georgia 30606 |
| Phone Number: | (706) 424-8438 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
J & M Shuler Medical Inc was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Shuler for inquiries that concern J & M Shuler Medical Inc by calling the company number (706) 424-8438, as your correspondence is most welcome. Additionally, the physical location of the single location of J & M Shuler Medical Inc can be found at the coordinates 33.944473,-83.392679 as well as the street address 530 West Cloverhurst Avenue in Athens, Georgia 30606.
For its online presence, you may visit J & M Shuler Medical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.